AL-53817 ophthalmic solution

· Alcon Research

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AL-53817 ophthalmic solution, covering 2015-08-06 to 2015-08-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis [Phase 2]